Physician profile
Nicholas Cooper Macpherson
NPI 1497097984
$7,008.00
in general payments reported to CMS, 2019-2025
38 companies · $1,877 in 2025
The $1,877 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.06 · 2020: $572 · 2021: $1,050 · 2022: $984 · 2023: $950 · 2024: $1,554 · 2025: $1,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,381.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,024.95 | 2020-2025 | |
| Endologix LLC | $766.39 | 2020-2025 | Alto Abdominal Stent Graft System |
| Heartflow, INC. | $609.28 | 2021-2025 | |
| Cleerly, INC. | $578.31 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Pfizer INC. | $431.02 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $357.89 | 2022-2025 | Jardiance |
| Boston Scientific Corporation | $306.40 | 2022-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $282.67 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $260.40 | 2020-2025 | Repatha, Repatha |
| Medtronic, INC. | $249.06 | 2021-2023 | Micra, Corevalve Evolut R |
| Abbott Laboratories | $240.83 | 2019-2025 | Jot Dx, Ensite |
| Astellas Pharma US INC | $213.93 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $189.21 | 2020-2024 | Xarelto |
| Arineta, INC | $176.89 | 2024 | Spotlight |
| Esperion Therapeutics, INC. | $173.09 | 2020-2023 | Nexletol |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $133.30 | 2021-2025 | Verquvo |
| Cardiovascular Systems INC. | $126.01 | 2023 | Diamondback Peripheral |
| Amarin Pharma, INC. | $117.44 | 2021-2022 | |
| Bridgebio Pharma, INC. | $85.99 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $81.20 | 2023 | Inpefa |
| Sanofi-Aventis U.S. LLC | $78.38 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $75.67 | 2022-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.39 | 2024 | Lifevest |
| Silk Road Medical, INC. | $49.95 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Stryker Corporation | $46.00 | 2025 | Flowtriever |
| W. L. Gore & Associates, INC. | $37.80 | 2021 | |
| Tactile Systems Technology INC | $37.34 | 2020-2022 | |
| Reflow Medical INC | $32.48 | 2024 | |
| Bolton Medical INC | $24.31 | 2024 | Treo Abdominal Stent-Graft System |
| Impulse Dynamics (USA) INC. | $24.08 | 2022 | |
| Vital Connect, INC | $22.07 | 2025 | Vitalpatch Rtm |
| Avinger INC. | $18.29 | 2021 | |
| Ge Healthcare | $17.99 | 2025 | |
| Scpharmaceuticals INC. | $17.98 | 2023 | |
| Irhythm Technologies, INC. | $16.74 | 2024 | Zio Xt Patch, Zio Monitor |
| Medicomp INC | $16.60 | 2022 | |
| Chiesi USA, INC. | $13.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Macpherson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.